Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st December 2025
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has filed its Annual Secretarial Compliance Report for the financial year ended 31st December 2025 with BSE and NSE, as required under SEBI LODR Regulation 24(A). The report, issued by BNP & Associates, Company Secretaries, confirms that the company has complied with all applicable SEBI regulations, including insider trading rules, listing obligations, takeover code, and depositories regulations. The company follows a calendar year (January–December) as its financial year, as it is a subsidiary of a foreign parent needing consolidation alignment. No actions were taken by SEBI or stock exchanges against the company during the review period, and no additional non-compliance was observed. The report does draw attention to Para 1.2.2 of the earlier Secretarial Audit Report dated 25.02.2026, which references observations by the Statutory Auditor regarding related party transactions.
This is a routine annual compliance filing indicating the company maintains proper board processes and compliance mechanisms with no new regulatory violations. The mention of related party transaction observations from the statutory auditor is a minor flag worth monitoring, but no fresh penalties or non-compliance have been reported.